CenExel is proud to announce that the work of David Walling, PhD, CEO and Principal Investigator at CenExel CNS, joined lead author, John H Krystal, as co-author of the recent Cerevel Therapeutics study titled, Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial, published in The Lancet.
News at CenExel
RSV: Perspectives and Insight from a Healthcare Hero
As a former healthcare worker at Primary Children’s Hospital in Salt Lake City, UT, I begin to get more and more concerned about cold and flu season as it pertains to babies, as passing on a simple adult cold to an infant could be dangerous, even life-threatening....
Clostridium Difficile or C-Diff: Causes & Symptoms
The bacterium Clostridium difficile, also called “C-Diff”, causes a range of symptoms in the human digestive symptoms ranging from severe diarrhea to a life-threatening inflammation of the colon. To avoid serious complications of C-Diff, it is important to learn its...
Pediatric Meningitis: Learn to Identify the Symptoms
Pediatric meningitis is a serious condition that can put your child or teen’s health at risk. Because meningitis is easily spread among individuals in close quarters, children who attend Salt Lake City schools or daycares are at an increased risk of contracting the...
Pediatric Flu: 6 Treatment Tips for Parents
Caring for a sick child can be incredibly stressful for a parent. This is especially true when a child is infected with the pediatric flu. Thousands of children in Salt Lake City experience the pediatric flu each year; however, many of these cases can be prevented...
Investigational Clostridium Difficile Vaccine Press Release
JBR Clinical Research is proud to be participating in the clinical trial for an investigational Clostridium Difficile vaccine. In a press release from May 19, 2014, the following positive results were reported: "C. diff infection threatens the many people who...